|Articles|April 1, 2016
- Applied Clinical Trials-04-01-2016
- Volume 25
- Issue 4
Applied Clinical Trials, April/May 2016 Issue (PDF)
Click the title above to open the Applied Clinical Trials April/May 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 10 years ago
Califf: More Informative Clinical Research Key to Drug Developmentover 10 years ago
EMA Releases New Advice on Human Trials for Cancer Drugsover 10 years ago
Number of Countries in Phase III Studies Remains Steadyover 10 years ago
Will EMA Rules Calm the Disclosure Debate?over 10 years ago
Acknowledging Cycle Time Impact from Protocol Amendmentsover 10 years ago
The Promise of Precision Medicineover 10 years ago
Value-Based Planning & Drug Development Productivityover 10 years ago
Overcoming Early Phase Oncology Challengesover 10 years ago
Imagining the Impossible: Immunity to CancerAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Portfolio-Level Recruitment Strategy, Real-Time Burden Sampling, and Platinum-Free Bladder Cancer Therapy
2
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
3
ACT Brief: FDA CRL Transparency Pause, Protocol-Centric Recruitment Model Shift, and Medical Affairs Integration in Development
4
Before Burden Becomes Risk: Capturing Friction in Real Time
5